Sort
23,748 grants matching “melanoma”
Investigating a novel shelterin-associated protein complex in telomere protection
$166,619Weidong Wang · National Institute On Aging · ZIA · FY2021 · AG
Chemical biology of superstolides--a novel class of anticancer natural products
$166,555Zhendong Jin · University Of Iowa · R21 · FY2017 · CA
Nanoparticle peptide-based therapy for melanoma
$166,488Frank Bedu-Addo · Pds Biotechnology Corporation · R43 · FY2008 · CA
REGULATORY MECHANISMS OF THE MDA5-MEDIATED ANTIVIRAL INTERFERON RESPONSE
$166,443Michaela Ulrike Gack · Harvard Medical School · P51 · FY2011 · RR
MSKCC Core Site
$166,392Susan E Krown · University Of California Los Angeles · U01 · FY2014 · CA
Imaging Apoptosis for Chemotherapy Responses
$166,388University Of Pittsburgh At Pittsburgh · R21 · FY2005 · CA
Lymph Node Alterations in Cancer
$166,387M Alanna Ruddell · University Of Washington · R01 · FY2012 · CA
Multimodal multifocal confocal Raman and phase microscopy with enhanced resolution
$166,359Peter T. So · Massachusetts Institute Of Technology · P41 · FY2019 · EB
Senior Leadership
$166,337Dario C. Altieri · Wistar Institute · P30 · FY2016 · CA
Statistical Methods for Analyzing Antigen Receptors Data
$166,209Grzegorz A Rempala · Augusta University · R01 · FY2012 · CA
Award of Task Order 3 entitled "A Dual AKT/PDPK1 Inhibitor for Actinic Keratosis and Skin Cancer Prevention in Immunocompromised Individuals"
$166,186Alexander Lyubimov · University Of Illinois At Chicago · N01 · FY2024 · CA
Administrative Core
$166,167Jane Amanda Skok · New York University School Of Medicine · P01 · FY2021 · CA
The RAC1 Pathway as aTarget for Melanoma Therapy
$166,133Joseph Schlessinger · Yale University · P50 · FY2012 · CA
Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy
$166,107Carlos M Rinaldi-Ramos · University Of Florida · R21 · FY2023 · CA
Molecular Diversity of Melanomas and Response to Targeted Therapy
$166,052Ruth Halaban · Yale University · P50 · FY2012 · CA
Regulation of cell homeostasis by fbx4
$166,000J. Alan Diehl · University Of Pennsylvania · R01 · FY2010 · CA
ANTI-GANGLIOSIDE IgM IN DIAGNOSING PROSTATE CANCER
$165,927Mepur H Ravindranath · Saint John'S Cancer Institute · R21 · FY2006 · CA
99mTc-Tilmanocept for Sentinel Lymph Node Biopsy in Cervical Cancer Surgeries
$165,917Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2014 · CA
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
$165,844Binfeng Lu · University Of Pittsburgh At Pittsburgh · R21 · FY2013 · CA
Pilot Clinical & Molecular Analysis of Atypical Nevus Response to Sulforaphane
$165,844John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · R21 · FY2012 · CA
DORMANCY VERSUS PROGRESSION OF HUMAN PRIMARY MELANOMA
$165,843Sunnybrook &Women'S Coll Hlth Scis Ctr · R01 · FY2002 · CA
Women's Health Initiative Cancer Survivor Cohort
$165,708Garnet L. Anderson · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · CA
Clinically Annotated Human Melanoma for TMEN Research
$165,635Keith T Flaherty · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
Oncogene Mutation Profiling in Uveal Melanoma
$165,616Ivana Kim · Massachusetts Eye And Ear Infirmary · R21 · FY2011 · CA
Data Bank & BioRepository
$165,573Christine B. Ambrosone · Roswell Park Cancer Institute Corp · P30 · FY2012 · CA